The S&P BSE Sensex fell over 100 points amid high volatility witnsessed in trade on Monday.

Indian markets are expected to trade lower. Here is a list of twelve stocks which are likely to remain in focus today.

Dr Reddy's Laboratories is recalling over 55,000 bottles of Amlodipine besylate and Atorvastatin calcium tablets.

The firm has started recalling Divalproex Sodium extended-release tablets as it has failed dissolution tests.

Dr Reddy's Laboratories shares were trading at Rs 2,594 apiece on the BSE in afternoon trade, down 1.60 per cent from its previous close.

In the wake of patent expiries on three blockbuster drugs over the last six-seven months, an opportunity worth nearly $1.3 billion is up fo...

Ranbaxy net profit jumped four fold to Rs 1,246 cr for the quarter ended Mar, buoyed by gains from two exclusive drug launches in US.

Drug firm Ranbaxy Laboratories on Tuesday launched a generic version of Caduet, used for treating cardio vascular diseases, in the US marke...

Indian authorities have rejected the patent applications of GlaxoSmithkline’s anti-diabetic drug Avandia and Pfizer’s cholesterol lowering ...

Ranbaxy has settled most of its patent disputes with Pfizer, allowing it to launch a generic version of Lipitor from November 30, 2011. Ran...